申请人:Genentech, Inc.
公开号:US20140171407A1
公开(公告)日:2014-06-19
The invention relates to 1,7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
该发明涉及化合物公式为(I)、(I-a)和(I-b)的1,7-二氮杂咔唑化合物,其作为激酶抑制剂具有用途,更具体地作为检查点激酶1(chk1)抑制剂,因此具有作为癌症治疗药物的用途。该发明还涉及包括这些化合物的组合物,更具体地是包括这些化合物的制药组合物以及使用它们治疗各种癌症和高增殖性疾病的方法,以及使用这些化合物进行哺乳动物细胞的体外、原位和体内诊断或治疗,或相关病理条件的方法。